Company Filing History:
Years Active: 2022
Title: Dabin Liu: Innovator in Non-Alcoholic Fatty Liver Disease Research
Introduction
Dabin Liu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of non-alcoholic fatty liver diseases (NAFLD). His innovative work has the potential to impact many lives by providing new methods for diagnosis and treatment.
Latest Patents
Dabin Liu holds a patent for a method involving Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases. The invention provides a method for diagnosing or prognosing NAFLD by detecting the expression level of the Squalene Epoxidase (SQLE) gene. Additionally, it includes a kit and device useful for these methods. The invention also offers a method for treating NAFLD by suppressing SQLE gene expression or activity. He has 1 patent to his name.
Career Highlights
Dabin Liu is affiliated with The Chinese University of Hong Kong, where he continues to advance his research in liver diseases. His work is characterized by a commitment to improving health outcomes through innovative scientific approaches.
Collaborations
Dabin Liu has collaborated with notable colleagues, including Jun Yu and Chi-Chun Wong. Their combined expertise enhances the research efforts in the field of liver disease.
Conclusion
Dabin Liu's contributions to the diagnosis and treatment of non-alcoholic fatty liver diseases exemplify the impact of innovative research in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.